Whither seniors' pharmacare: lessons from (and for) Canada


Related Publications

Smolina K, Weymann D, Morgan S, Ross C, Carleton B. Association between regulatory advisories and codeine prescribing to postpartum women. Journal of the American Medical Association. 2015;313(18):1861-2.
Suter E, Misfeldt R, Mallinson S, Wilhelm A, Boakye O, Marchildon G, et al. Comparative Review of the Policy Landscape of Team-based Primary Health Care Service Delivery in Western Canada. Alberta Health Services; 2014.
Laberge M, Pang J, Walker K, Wong ST, Hogg W, Wodchis WP. QUALICOPC (Quality and Costs of Primary Care) Canada: A focus on the aspects of primary care most highly rated by current patients of primary care practices. Ottawa, ON: Canadian Foundation for Healthcare Improvement; 2014.
McGregor MJ, Abu-Laban RB, Ronald L, McGrail KM, Andrusiek D, Baumbusch J, et al. Nursing Home Characteristics Associated with Resident Transfers to Emergency Department. Canadian Journal on Aging. 2012;33(1):38-48.

Publication Topics

Whither seniors' pharmacare: lessons from (and for) Canada

Publication TypeJournal Article
Year of Publication2003
AuthorsMorgan SG, Barer ML, Agnew JD
JournalHealth affairs (Project Hope)Health.Aff.(Millwood)
Pages49 - 59
Date Published2003
KeywordsAged, Canada, Cost Control/methods, Cost Sharing/legislation & jurisprudence, Drug Costs/legislation & jurisprudence, Drug Prescriptions/economics, Drug Utilization Review, Economic Competition, Formularies as Topic, Health Services for the Aged/economics, Humans, Insurance, Pharmaceutical Services/economics/legislation & jurisprudence, National Health Programs/economics/organization & administration, Politics, Poverty
AbstractCanada's provincial governments have, until relatively recently, provided virtually all seniors with generous prescription drug coverage. Managers of these programs have implemented a variety of policies to contain spending while ensuring access to necessary medicines. Some of these policies have been successful in temporarily slowing cost growth. However, the lack of comprehensive utilization management tools has resulted in ongoing spending increases that now constitute a threat to the sustainability of a public drug subsidy for Canadian seniors. Sustainable and equitable pharmacare programs require the political willingness to confront opposition to policies that will, if successful, contain program costs without obstructing access.
Citation Key446